Regional Strain Predicts VT/VF in HFrEF
myocardial contraction pattern determined by evaluating the dispersion of mechanical contraction have been demonstrated useful predictors for ventricular arrhythmias. [6] [7] [8] 11 However, both GLS and mechanical dispersion (MD) are based on averaging regional differences in deformation timing and amplitude, and important abnormalities in regional function may be missed by dilution in this process. Furthermore, the local radius of curvature of the ventricle increases from the apex to the base of the heart and also from the lateral to the septal wall. 12, 13 Regions with more flattened structure, such as the inferior region, exhibit a higher radius of curvature, 12, 13 which entails an intrinsically higher wall stress. In addition, the relative contribution of the sympathetic or parasympathetic innervation is differentially distributed within the LV.
14 These discrepancies in the workload the myocytes perform, caused by regional anatomic differences, and differences in autonomic innervation, may result in regional dissimilarities in the prognostic information on the risk of ventricular arrhythmias that can be obtained from deformation analysis.
Therefore, we hypothesized that measures of regional longitudinal deformation by 2DSE are significant predictors of ventricular tachyarrhythmias, and they may improve prediction of ventricular tachyarrhythmias over clinical and conventional echocardiography parameters, in patients enrolled in the MADIT-CRT study (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
Methods

Study Population
The MADIT-CRT trial enrolled patients with nonischemic HF in New York Heart Association functional classification class II and ischemic HF in New York Heart Association class I or II, in sinus rhythm, an LVEF of ≤30%, and a QRS duration of ≥130 ms. From December 2004 to April 2008, a total of 1820 patients were enrolled. Patients Continuous Gaussian-distributed variables are represented by the mean and SD. Continuous non-Gaussian-distributed variables are represented by the median and interquartile range. Categorical variables are represented by numbers and proportions. ACE indicates angiotensin-converting enzyme; BNP, B-type natriuretic peptide; BP, blood pressure; BUN, blood urea nitrogen; CABG, coronary artery bypass graft; CRT-D, cardiac resynchronization therapy-defibrillator; NYHA, New York Heart Association; LBBB, left bundle branch block; RBBB, right bundle branch block; VF, ventricular fibrillation; and VT, ventricular tachycardia. Regional Strain Predicts VT/VF in HFrEF were randomly assigned in a 3:2 ratio to receive CRT-D (CRT plus an ICD) or ICD alone. Additional details on inclusion and exclusion criteria have been previously reported. 15 Echocardiograms were obtained according to a study-specific protocol at baseline before device implantation. A total of 1077 patients (ICD, n=416; CRT, n=661) had image quality sufficient for speckle-tracking analysis. Patients with insufficient echocardiographic quality who were excluded from analysis were patients whose images were in non-Digital Imaging and Communications in Medicine format or the frame rate was <30 Hz (n=607) or because of missing 4-or 2-chamber views, insufficient 2D image quality, use of echocardiographic contrast agents, the presence of endocardial dropout, or out-of-plane images (n=136). Patients with sufficient image quality for speckle-tracking analysis have previously been compared with those with insufficient image quality, and they only differed significantly in QRS duration and the frequency of reported diabetes mellitus. 16 Thirteen patients were additionally excluded because of missing data on ventricular arrhythmias because they did not have an ICD device implanted. The study population comprising this analysis therefore consisted of 1064 patients from the MADIT-CRT trial. Besides QRS duration and frequency of reported diabetes mellitus, 16 the present population only differed significantly in a slightly lower frequency of previous atrial fibrillation and slightly higher proportion of patients receiving a CRT (Table I in the Data Supplement). The study was approved by institutional review committees, and the subjects gave written informed consent.
Echocardiography
All echocardiograms were analyzed offline at the independent echocardiography core laboratory at Brigham and Women's Hospital, Boston.
Conventional echocardiographic parameters, including LV and left atrium (LA) volumes together with LVEF, were analyzed using an offline analysis work station as previously described. 17 A B-mode 2D speckle-tracking software (TomTec Imaging Systems, Unterschleissheim, Germany) was used to assess LV myocardial deformation; this method has been demonstrated to have excellent reproducibility in our laboratory when used in clinical trials 18, 19 and also in the present study population. 16 The endocardial border was traced in the end-systolic frame of the apical 4-and 2-chamber views. Speckle tracking was performed over the course of ≥2 cardiac cycles. The basal, mid, and apical regions were tracked, and the peak strain value was obtained from each region. The tracking of each region was carefully inspected and manually adjusted if needed. If >2 segments could not be tracked, the measurements were considered unreliable and the echocardiographic examination was excluded from the analysis. For each myocardial wall, the average strain was calculated from the basal, mid, and apical regions, creating strain measures obtained from the septal, lateral, anterior, and inferior myocardial walls. Mechanical dyssynchrony, also known as MD, was assessed by the SD of the time-to-peak longitudinal strain in the apical 4-and 2-chamber views, using 12 segments. 11 Tracings in each view were performed by a single investigator blinded to treatment assignment, clinical/demographical data, and clinical outcomes.
Follow-Up and Outcome
Commercially available transvenous single-or dual-chamber ICD and CRT-D devices (Boston Scientific) were implanted in this study, using standard techniques. 20 Devices were programmed with a recommendation of setting the ventricular tachycardia (VT) zone at 180 bpm and ventricular fibrillation (VF) zone at 210 bpm. Sensitivity was programmed based on physician discretion. Detection was 2.5 s for the VT zone and 1.0 s for the VF zone. The prespecified study protocol recommended programming the VT zone therapy to burst-type antitachycardia pacing with 8 pulses at 88% of the measured cycle length with 10-ms decrement between bursts, and subsequent shock therapy, with the second suggestion of setting the shock at defibrillation threshold plus at least 10 J. The additional shock therapies were suggested as being maximal energy shocks.
Patients had a clinic follow-up 1 month after the device implantation and then every 3 months until the end of the trial or in case of HF or arrhythmic events. Clinical evaluation and ICD interrogation were performed at each follow-up visit. The ICD interrogation disks at follow-up and after ICD shocks were sent to the interrogation core laboratory (Stanford University, Dr. Paul J. Wang) for categorization and final evaluation of detected arrhythmias with ICD therapy (antitachycardia pacing or shock).
Arrhythmia episodes were defined as any type of therapy delivered including antitachycardia pacing and shocks. Definition of VT was set to a rate from 180 bpm (recommended programming) up to 250 bpm, ventricular (V) rate≥atrial (A) rate if 1:1 A:V, V-V changes drive A-A changes. VF was defined as ventricular rate of >250 bpm with disorganized ventricular electrocardiograms. Only appropriate therapy delivered for VT or VF was considered in the present analysis. Arrhythmia episodes were adjudicated by an independent 
Statistical Analysis
Proportions were compared using χ 2 test, continuous Gaussiandistributed variables with Student t test, and Kruskal-Wallis test if non-Gaussian distributed. Hazard ratios (HRs) were calculated by Cox proportional hazards regression analyses. The assumptions of proportional hazards were tested in all Cox models using the Schoenfeld residuals. No significant violations were detected in any of the Cox regressions. Harrell C statistics 21 obtained from univariable Cox proportional hazards regression models were calculated to test the prognostic performance of regional longitudinal strain. Furthermore, the Harrell C statistics were obtained from multivariable Cox proportional hazards regression models including all the conventional risk factors of VT/VF (treatment group, age, sex, systolic blood pressure, diabetes mellitus, left bundle branch block [LBBB], ischemic origin, smoking status, previous ventricular arrhythmias, LVEF, and LA volume index) and compared with Harrell C statistics obtained from multivariable Cox proportional hazards regression models including all the conventional risk factors and GLS, strain obtained from the anterior or inferior myocardial wall. Poisson models were used to estimate the incidence rates. Subdistribution HRs were calculated by competing risk Cox proportional hazards regression analyses with all-cause mortality as the competing risk (Table II in the  Data Supplement) . P values for trends were calculated (for continuous Gaussian-distributed variables obtained by regression analysis and by an extension of the Wilcoxon rank-sum test for continuous non-Gaussian-distributed variables and by a χ 2 test for proportions). The inferior strain cutoff, which best discriminated high-risk from low-risk patients, was assessed using Cox regressions where inferior strain was dichotomized into high/low groups using decrements of 0.5% in inferior strain, and the accompanying P values were determined. The cutoff value conferring the most statistically significant HR was chosen as the optimal cutoff. P≤0.05 in 2-sided test was considered statistically significant. All analyses were performed with STATA statistics/data analysis, SE 12.0 (StataCorp, TX). Association between regional strain and risk of ventricular tachyarrhythmias. Depicting the incidence rate of ventricular tachycardia/ventricular fibrillation (events per 100 patients-years) on the y-axis and regional strain on the x-axis for the whole cohort (A) and for patients stratified according to cardiac resynchronization therapy (CRT) or implantable cardioverter defibrillator (ICD) (B). The curves depict the incidence rate with 95% confidence intervals of the estimates, respectively. Poisson models were used to estimate the incidence rates. Histograms show the population distribution of regional strain. Regional Strain Predicts VT/VF in HFrEF
Results
Baseline characteristics are displayed in Tables 1 and 2 . During the follow-up (median follow-up 2.9 years; interquartile range, 2.0-3.7 years), 254 (24%) patients experienced ≥1 episodes of VT or VF.
Patients developing VT/VF were significantly younger, more often men, they more often had a history of previous VT/VF events, they less often had diabetes mellitus, but more often had ischemic heart disease and myocardial infarction, lower systolic blood pressure, shorter QRS, and lower proportion of LBBB when compared with patients with no VT/ VF events (Table 1) . Patients in the CRT-D arm had lower risk of VT/VF than patients in the ICD arm (Table 1) . For the echocardiographic parameters, only LV mass index and MD as determined by SD of the time-to-peak strain measures were not significantly more impaired in the VT/VF group (Table 2) .
Regional Deformation and Risk of Ventricular Arrhythmias
The risk of VT/VF increased with decreasing longitudinal strain in all myocardial walls (Table 2 ; Figures 1 and 2) . However, treatment with CRT modified the relationship between regional strain and risk of VT/VF in the septal wall (P for interaction, 0.008; HR in the ICD group of 1.12 [1.07-1.19]; P<0.001 and HR in the CRT group of 1.03 [0.98-1.07]; P=0.27, per 1% decrease in septal strain; Figure 1 ). Treatment did not modify the relationship between regional strain and risk of VT/VF for any other cardiac myocardial wall. All subsequent analysis were therefore adjusted for the treatment group rather than stratified by the treatment group. Besides treatment, we also tested whether the relationship between regional strain and risk of VT/VF was modified by sex, ischemic origin, LBBB, and QRS duration. Neither of these tests for interaction was found to be statistically significant.
The prognostic utility of regional strain for predicting future VT/VF differed depending on which LV wall displayed abnormalities in strain (Tables 3 and 4 ; Figure 2 ). This became evident after multivariable adjustment for the treatment group, age, sex, systolic blood pressure, diabetes mellitus, LBBB, ischemic origin, smoking status, previous ventricular arrhythmias, LVEF and LA volume index, where only decreasing strain in the anterior and inferior myocardial walls remained independent predictors of VT/VF (Table 3 ; Figure 2 ). In a small subset of patients from the MADIT-CRT trial who had B-type natriuretic peptide available (n=676), we found that when also including B-type natriuretic peptide in the model, HR estimates for regional strain measures remained largely the same, but only decreasing strain in the inferior myocardial wall remained an independent predictor of VT/VF (HR, 1.05 [1.00-1.11]; P=0.039 per 1% decrease in inferior strain). In comparison, GLS did not remain an independent predictor of VT/VF when adjusted for the same variables (HR, 1.05 [0.97-1.12]; P=0.23 per 1% decrease in GLS strain).
In addition, when including strain from all the walls in the same Cox regression model and adjusting for the treatment group, only decreasing strain obtained from the anterior and inferior walls remained independent predictors of VT/VF and the test for differential prognostic information between the different walls was found to be statistically significant (P=0.018; Table 4 ). The same pattern was found after multivariable adjustment; the test for differential prognostic information between the different walls was found to be even stronger (P=0.006; Table 4 ). When judging from the C statistics values, consistent results were confirmed; decreasing strain in the inferior myocardial wall resulted in the highest C statistics followed by the anterior myocardial wall (Table 3) .
Importantly, when including GLS in the multivariable models already including the treatment group, age, sex, systolic blood pressure, diabetes mellitus, LBBB, ischemic origin, smoking status, previous ventricular arrhythmias, LVEF, LA volume index, and either anterior or inferior strain, resulted in only decreasing strain obtained from the inferior myocardial wall remained an independent predictor of VT/VF (GLS: P>0. 40 
Incremental Prognostic Information on Future VT/ VF When Assessing Regional Deformation
We found that both strain obtained from the anterior myocardial and strain obtained from the inferior myocardial wall remained independent predictors of VT/VF after multivariable adjustment (Tables 3 and 4) . We therefore assessed whether any of these deformation measures also provided incremental prognostic information to the known predictors of VT/ VF in our population. We found that only when adding strain obtained from the inferior myocardial wall (not GLS and anterior strain) led to a significant increase in the Harrell C statistics (0.69 versus 0.71; P=0.005; Figure 3) . Decreasing strain in the inferior myocardial wall was significantly associated with higher proportion of male sex, higher heart rate, higher proportion of previous ventricular arrhythmias, higher proportion of diabetes mellitus, higher proportion with ischemic cardiomyopathy, higher blood urea nitrogen, lower systolic blood pressure, higher proportion of right bundle branch block, lower proportion of LBBB, and higher B-type natriuretic peptide. In addition, decreasing strain in the inferior myocardial wall was significantly associated with impaired echocardiographic measures of LV structure (larger LV mass index and LV end-diastolic volume index) and worse systolic (lower LVEF, GLS, and regional strain) and diastolic function (larger LA volume index), and MD (higher SD time to peak; Table 5 ). We also assessed the association between strain obtained from the anterior myocardial wall and clinical parameter, which is displayed in Table III in the Data  Supplement. The risk of VT/VF increased linearly with decreasing strain of the inferior wall ( Figure 1) ; however, the cutoff that best discriminated high-risk from low-risk patients was an inferior strain of −7%, which resulted in the most significant risk discrimination. Patients with an inferior strain lower than 7% (closer to zero) had a >2-fold increased risk VT/VF when compared with patients with an absolute inferior strain of ≥7% (more negative and further from zero; HR, 2.10 [1.63-2.69]; P<0.001).
Sensitivity Analyses
When taking all-cause mortality as a competing risk into account, we found consistent results; only decreasing strain obtained from the anterior and inferior walls remained as independent predictors of VT/VF and the test for differential prognostic information between the different walls was found to be statistically significant (Table II in the Data Supplement) . Interestingly, when predicting all-cause mortality instead of VT/VF, there was no difference in the predictive capabilities of a decreasing strain between the different myocardial walls (P value for difference in prognostic utility between strain obtained from the different walls was 0.62).
Similarly, we also tested whether the pattern was different in patients with ischemic (n=592) and nonischemic (n=472) HF, but the results were similar, regardless of HF cause (Tables IV  and V in the Data Supplement) . Finally, we also tested whether the results were similar when restricting our population to only men (Table VI in the Data Supplement). This restricted analyses displayed similar results as when assessing the predictive value of regional deformation in the whole cohort.
Discussion
In the present study, we assessed the usefulness of regional longitudinal deformation in predicting ventricular tachyarrhythmias in 1064 patients with HF with reduced EF (HFrEF) enrolled in the MADIT-CRT trial. We demonstrate that the prognostic importance of longitudinal deformation to predict future ventricular tachyarrhythmias differs by LV region. Importantly, we found that impaired longitudinal deformation especially in the inferior (and to a lesser extent in the anterior) myocardial wall is a paramount marker of increased risk for ventricular tachyarrhythmias (Figure 4 ). Decreasing strain in the inferior myocardial wall not only is an independent predictor of future VT/VF but also provides incremental predictive information to other important predictors of ventricular tachyarrhythmias.
Myocardial Deformation and Prognosis
Quantifying LV systolic function is vital in predicting adverse outcome in patients with HFrEF. 22 Two-dimensional DSE has in recent years emerged as a method for assessing LV systolic function, 23 by obtaining GLS, which has previously been demonstrated to be a strong predictor of outcome in patients having a wide array of cardiac diseases, including patients experiencing HFrEF. 22 Similarly, when assessing risk of ventricular arrhythmias, GLS has been demonstrated to be a useful echocardiographic 8 In addition, a heterogeneous myocardial contraction pattern determined by a dyssynchronic ventricular contraction (known as MD or dyssynchrony) has also been demonstrated useful to predict ventricular arrhythmias. 6, 7 In contrast to previous studies, [24] [25] [26] we did not find MD to be a strong predictor of ventricular tachyarrhythmias (Table 2 ). This might be because of the fact that we only obtained MD from 12 segments (apical 4-and 2-chamber views) instead of 18 segments or because 2DSE was performed on Digital Imaging and Communications in Medicine images leading to lower frame rates than used in previous studies. However, recent studies using 18 segments and high frame rate have also questioned this measure as a specific marker of ventricular tachyarrhythmia risk in HFrEF. 10, 27 Despite the limitations, the MADIT-CRT trial is the largest study to date testing the usefulness of MD in HFrEF patients with continues rhythm monitoring and found that this measure at baseline was not a univariable predictor of VT/VF. 11 Likewise, in a large study of patients after MI, MD was found to be a significant predictor of ventricular tachyarrhythmias; however, GLS was found to be a superior predictor when compared with MD. 8 Whether MD is a specific or sensitive marker of ventricular tachyarrhythmia risk in HFrEF therefore needs to be evaluated further. However, both GLS and MD are based on averaging regional differences in deformation timing and amplitude, and information on regional function may be diluted in this process. Indeed, recent studies have implied that assessing regional impairment or deformation may be more accurate, both for diagnostic or prognostic purposes. 9, 10, [28] [29] [30] [31] [32] In the present study, we found that a decreasing longitudinal function in certain regions of the LV, determined by decreasing strain, were strong predictors of VT/VF. Impaired longitudinal deformation in these regions were a strong marker of increased risk of VT/VF, more important than a decreased global LV function (as determined by GLS or LVEF), and more important than a dyssynchronous ventricular contraction as assessed by MD. Interestingly, when predicting all-cause mortality, we did not find a significant difference in the prognostic capabilities of regional deformation, suggesting that the prognostic significance of these regional differences is specific for assessing risk of ventricular arrhythmias. Several features might influence the usability of regional deformation in assessing the risk of VT/VF. First, as mentioned previously, the anatomic structure of the LV is not uniform between the different walls. Regions with more flattened structure, such as the inferior wall, exhibit a higher radius of curvature, 12,13 which entails an intrinsically higher wall stress and may predispose to significant remodeling in these segments resulting in regional dissimilarities in the prognostic information on the risk of ventricular arrhythmias that can be obtained from deformation analysis. In accordance with our results, a previous study including patients with ICD implantation and ischemic heart disease found that an akinetic pattern localized to the right coronary region (inferior and posterior regions) was an independent and incremental predictor of ICD events and all-cause mortality. 9 Likewise, impaired longitudinal deformation in the inferior myocardial wall as assessed by tissue Doppler imaging was the strongest predictor of ventricular arrhythmias and cardiovascular mortality in patients with ischemic cardiomyopathy. 10 Impaired deformation, as assessed by circumferential strain, in these same regions of the LV (inferior and posterior regions) have recently been demonstrated to be present significantly more frequent than impaired deformation in other regions of the LV among patients with VT/VF. 30 Therefore, regardless of the method, wall motion score index, 9 tissue Doppler imaging 10 or 2DSE, 30 impaired myocardial function of the inferioposterior region seem to confer a high risk of ventricular tachyarrhythmias. It has been hypothesized that the inferoposterior regions of the LV are innervated by greater parasympathetic (vagal) afferents, and a deceased or ailing myocardium in these regions may alter or destroy the parasympathetic Model 1 includes strain obtained from all the myocardial walls and treatment group. Model 2 includes strain obtained from all the myocardial walls and the treatment group, age, sex, systolic blood pressure, diabetes mellitus, left bundle branch block, ischemic origin, smoking status, previous ventricular arrhythmias, left ventricular ejection fraction, and left atrium volume index. Previous VT/VF, n (%) 13 (5) 15 (6) 12 (5) 28 (11) 0.017
Previous AF, n (%) 24 (9) 27 (10) 38 (15) 18 (7) 0.79
Diabetes mellitus, n (%) 65 (24) 67 (25) 76 (29) 84 (32) 0.044
Smoking, n (%) 32 (12) 29 (11) 40 (15) 28 (11) 0.90
Ischemic origin, n (%) 116 (44) 143 (54) 171 (64) 162 (61) <0.001
Revascularization, n (%) 64 (24) 78 (29) 82 (31) 75 (28) 0.27
Previous CABG, n (%) 63 (24) 75 (28) 83 ( Continuous Gaussian-distributed variables are represented by the mean and SD. Continuous non-Gaussian-distributed variables are represented by the median and interquartile range. Categorical variables are represented by numbers and proportions. ACE indicates angiotensin-converting enzyme; AF, atrial fibrillation; BNP, B-type natriuretic peptide; BP, blood pressure; BUN, blood urea nitrogen; CABG, coronary artery bypass graft; CI, confidence interval; CRT-D, cardiac resynchronization therapydefibrillator; GLS, global longitudinal strain; LAVI, left atrial volume index; LBBB, left bundle branch block; LVEDVI, left ventricular end-diastolic volume index; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; MI, myocardial infarction; NYHA, New York Heart Association; RBBB, right bundle branch block; SD T2P, SD of 12 segment time-to-peak strain; VF, ventricular fibrillation; and VT, ventricular tachycardia. Regional Strain Predicts VT/VF in HFrEF fibers, leading to autonomic dysfunction of the heart with higher arrhythmic potential. 9 Interestingly, in patients having a stroke, which is well known to cause an increased sympathetic tone 33 and impaired parasympathetic function 34 both of which are predisposing factors for sudden cardiac death, 35 impaired longitudinal function of the inferior wall has been demonstrated to be the strongest echocardiographic predictor of outcome. 29 Several studies have indicated that CRT treatment reduces the risk of VT/VF [36] [37] [38] [39] ; however, other studies have shown a proarrhythmic effect of CRT. [40] [41] [42] The mechanism by which CRT has been thought to reduce the risk of VT/VF has been attributed to the improved hemodynamic status and LV reverse remodeling.
5,39
Nevertheless, we describe in the present report that regardless of CRT treatment, an impaired inferior wall is a paramount marker of increased risk of VT/VF (Tables 3 and 4 ; Figures 1 through 3) .
We found that treatment with CRT only modified the association between strain obtained from the septal wall and risk of VT/VF (P for interaction 0.008; Figure 1 ). There was no effect modification by treatment with CRT on the association between strain obtained from any of the other walls and risk of VT/VF. Interestingly, despite the finding that low stain in the inferior wall confers the highest risk of ventricular tachyarrhythmias, for patients with low strain in the septal wall CRT treatment seemed to be especially useful in reducing the risk of VT/VF events (Figure 1) . A regional strain pattern of early low septal strain and delayed lateral strain has recently been demonstrated to benefit most from CRT treatment, which might explain our finding. 43 However, this pattern has not previously been assessed in the relation to VT/VF events.
Limitations
Several limitations have to be noted in the present study. First, our study was not designed to assess the potential mechanism triggering the difference in prognostic utility of longitudinal deformation between different regions. Hence, these findings require replication in independent cohorts before differences in longitudinal deformation between different walls might be used in the clinical setting to select candidates for ICD therapy. Unfortunately, data on MI location were not available. However, importantly, impaired myocardial deformation of the inferior wall (and to a less extent the anterior wall) was not only an independent predictor of VT/VF after adjustment for ischemic origin (Tables 3 and 4) but also the strongest predictor irrespective if patients had ischemic or nonischemic HF (Tables IV and V in the Data Supplement), indicating that impaired longitudinal deformation of the inferior wall conferred a high VT/VF risk, regardless if it is caused by ischemia or not. In addition, patients with an anterior MI generally have a larger area of scarred myocardium and a greater decrease in LVEF. This situation carries a greater risk of arrhythmic events and mortality. In contrast, patients with an inferior infarct are likely to survive their ischemic event longer and harbor a , anterior strain of −7.2%, and inferior strain of −5.4%. The 2 patients therefore had comparable clinical characteristics and anterior strain but very different inferior strain and different outcomes. The basal inferior strain curves (green curves) are especially different between the 2 patients. GLS indicates global longitudinal strain. Regional Strain Predicts VT/VF in HFrEF greater arrhythmogenic ventricular milieu. However, we tried to assess whether this might explain our results by assessing whether they would change by performing a competing risk analysis with all-cause mortality as the competing risk, which did not change our results (Table II in the Data Supplement) .
In MADIT-CRT, strain was not assessed in the apical long-axis view, but only in the apical 4-and 2-chamber views, and GLS and MD were therefore calculated from only 2 apical views instead of 3. 11, 16 In addition, wall motion score index was not determined in the present study. Nevertheless, 2DSE has previously been demonstrated as a more feasible and more reliable technique for the quantification of myocardial deformation than wall motion score index. 44 
Conclusion
In patients with HFrEF, enrolled in MADIT-CRT, assessment of regional longitudinal myocardial deformation predicted ventricular arrhythmias and provided incremental prognostic information over clinical and conventional echocardiographic risk factors. Impaired longitudinal deformation in the inferior myocardial wall is a paramount marker of subsequent VT/VF that could be utilized to identify high-risk patients for VT/VF in whom close follow-up and additional substrate modification may be necessary.
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